Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Hepatitis C, Chronic × ledipasvir × Clear all

Phase

Phase 4 1 Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Recurrence 1 Hepatitis C, Chronic 1 Carcinoma, Hepatocellular 1

Interventions

Ribavirin 3 peginterferon alfa-2a 2 sofosbuvir-velpatasvir drug combination 1 ledipasvir 1 Sofosbuvir 1 Introns 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02959359 2017-08-07

DAA in the Risk of Recurrence After Curative Treatment of HCC

Taipei Veterans General Hospital, Taiwan

Phase 4 Withdrawn

Gastrointestinal

Carcinoma, Hepatocellular, Recurrence, Hepatitis C, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡